We’re (not just) investors. We’re (more than) advisors. We’re (beyond) connectors.  Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives.   For over 30 years, Ben has been the leading seed stage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.

Ben Franklin Technology Partners of Southeastern Pennsylvania

Dreamit is a leading venture fund focused on startups with revenue or pilots that are ready to scale. Dreamit specializes in startups building transformative companies in Securetech. Founders meet with dozens of potential customers and partners on Customer Sprints® and pitch leading venture firms during Investor Sprints®. Since its founding in 2008, Dreamit has partnered and helped grow over 320 startups, including LevelUp (acquired by GrubHub), Trendkite (acquired by Cision), SeatGeek, HouseParty (acquired by Epic Games), Elevate, Adaptly (acquired by Accenture), Wellth, Biomeme, Tissue Analytics (acquired by Net Health), Redox, Eko Devices, NestEgg, Cherre, Cylera, RaySecur, SpecTrust, Tidal Cyber, TestifySec, Nirmata, and Accuknox.

Dreamit Ventures

BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its new  $50 million Greenhouse Fund. They invest in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date they have committed more than $40 million to more than 50 seed-stage companies and 17 pre-seed companies. Their portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement monies.

BioAdvance

500 Global is a multi-stage venture capital firm with US$2.4 billion in assets under management that invests in founders building fast-growing technology companies. We focus on markets where technology, innovation, and capital can unlock long-term value and drive economic growth. We work closely with key stakeholders and advise governments on how best to support entrepreneurial ecosystems so startups can thrive. 500 Global has backed over 5,000 founders representing more than 2,800 companies operating in 80+ countries. We have invested in 35+ companies valued at over US$1 billion and 160+ companies valued at over US$100 million (including private, public, and exited companies). Our 190+ team members are located in over 25 countries and bring experience as entrepreneurs, investors, and operators from some of the world’s leading technology companies. (*as of June 30, 2023)

500 Global

FundersClub focuses on Seed and early stage investments. Investments include Coinbase, Instacart, Flexport, Le Tote, Teespring, Memebox, GitLab. FundersClub is the world's first online venture capital platform. Backed by Y Combinator, First Round Capital, Spark Capital, Intel Capital, Draper, Andreessen Horowitz, Felicis Ventures, and more; FundersClub Inc. was founded in 2012 and is based in the United States.

FundersClub

A venture fund focused on digital health, medical device, and diagnostic startups.

Dreamit Healthtech

Alumni Ventures Group provides high-quality, diversified venture portfolios to individual investors who previously haven't had access to VC. It helps accredited alums from top entrepreneurial schools invest together in the ventures of fellow alums. The firm backs companies with an alumni connection and an institutional lead investor with expertise in the space. AVG also offers focused funds that allow any accredited investor access to a venture portfolio, diversified by type, sector, stage, and geography. Beth Obermiller, Michael Madden, and Mike Collins co-founded the firm in Manchester, New Hampshire in 2013.

Alumni Ventures

Space Capital is a venture capital firm investing in the Space economy, specifically focused on unlocking the value in Space technology stacks such as GPS, Geospatial Intelligence, and Communications.

Space Capital

Allevi

Allevi offers bioprinters that enable users to experiment with any biomaterial, work with any cell line, and print in any geometry. Its platform empowers novice and expert 3D bioprinting users alike to quickly and easily achieve their goals.

<div><p>Allevi offers bioprinters that enable users to experiment with any biomaterial, work with any cell line, and print in any geometry. Its platform empowers novice and expert 3D bioprinting users alike to quickly and easily achieve their goals.</p></div>

Enabling supply of biologically safe tissues and organs using next-gen printing tech

Bioprinting

<div>
  <p>
    Allevi offers bioprinters that enable users to experiment with any biomaterial, work with any cell line, and print in any geometry. Its platform empowers novice and expert 3D bioprinting users alike to quickly and easily achieve their goals.
  </p>
</div>


<div>
  <p>
    3D Bioprinting Solutions is a biotechnological research laboratory that develops and produces 3D bioprinters and bioprinting materials.
  </p>
</div>


3D Bioprinting Solutions

<div>
  <p>
    3Dynamic Systems
  </p>
</div>


3Dynamic Systems

<div>
  <p>
    A.D.A.M. (Advanced Development of Additive Manufacturing) is a biotech company that provides 3D-bioprinting services on demand. A.D.A.M. uses its proprietary 3D-printing technology and patented materials to manufacture bioresorbable and biodegradable patient-specific implants (primarily, bone implants). By designing and building an on-demand tissue manufacturing solution, we have been pioneering this technology as a service model to effectively address a complex problem. The business model will allow patients to have their tissue modelled – using the MRI/CAT scans stored on the digital platform – and, subsequently, 3D-printed and implanted in certified clinics. We reached our main achievement to date in August, as the FDA responded to our Q-Sub (Pre-Submission) confirming our 510(k) regulatory path eligibility. This response means that no human trials and required and a decrease in time to market from 5 years to 1.5-2 years.    Additionally, we have been accepted to join Technology Incubation Program at University of Connecticut in Farmington, CT. We have just moved our main office there as TIP offers state of the art research facilities and resources to its member companies. Our intention is to complete the required animal studies there.    Finally, we have secured our lead investor for the upcoming Series A round.
  </p>
</div>


A.D.A.M.

<div>
  <p>
    Advanced BioMatrix is a leader in the life science of three-dimensional (3D) applications for tissue culture, cell assay, bioprinting, and cell proliferation. The company's products are recognized as the standard for purity, functionality, and consistency. Advanced BioMatrix has extensive expertise in production, isolation, purification, lyophilization, cell culture, and testing of proteins, adhesion peptides, attachment factors, bio-inks, substrate rigidity, and other 3D matrix products. Their expertise and knowledge are being employed to assure that their products are of the highest quality, consistent from lot to lot, and easy to use for research customers. The company is located in the San Diego region – one of the world’s largest life science and biotechnology clusters. Advanced BioMatrix has been manufacturing and delivering high-quality products for research uses and applications for over 10 years. Advanced BioMatrix transforms science to a new level of discovery by providing advanced technologies through innovative 3D matrix products.
  </p>
</div>


Advanced Biomatrix

<div>
  <p>
    Advanced Solutions Life Sciences provides solutions for living organisms, molecular biology, and biotechnology.
  </p>
</div>


Advanced Solutions Life Sciences

3D printing enables bioprinting devices, which rely on a similar design and operating model

Startups in this hub are able to customize the bioprinted models to suit each patient

AI/ML is used in the design and optimization of 3D models that can be bioprinted

Companies that are developing materials and bioinks, that can be used in bioprinting devices. This includes material technologies and nanofibers.

Allevi

Bioprinting

Key stats

EDGE Insights

Print your heart out: Bioprinting and the future of organs

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless